A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer.
about
A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinomaPancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parametersRe-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreasPancreatic cancer: Open or minimally invasive surgery?Update on the management of pancreatic cancer: surgery is not enoughA Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts.Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasionDiagnosis and management of pancreatic cancer.Intensity of follow-up after pancreatic cancer resectionPredictors of survival in periampullary cancers following pancreaticoduodenectomy.Modeling prognostic factors in resectable pancreatic adenocarcinomas.The effect of metformin on survival of patients with pancreatic cancer: a meta-analysisBorderline resectable pancreatic cancer: definitions and management.Pancreatic adenocarcinomaPreoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure.Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 exprManagement of pancreatic cancer: current status and future directionsPeri-operative blood transfusion and operative time are quality indicators for pancreatoduodenectomyAdvances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial.Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancerIntraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancerSaudi Oncology Society clinical management guideline series. Pancreatic cancer 2014.Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancerExtended resection in pancreatic metastases: feasibility, frequency, and long-term outcome: a retrospective analysis.Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resectionA phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol.The detail of the en bloc technique and prognosis of spleen-preserving laparoscopic distal pancreatectomy for pancreatic cancerRare long-term survivors of pancreatic adenocarcinoma without curative resection.An anatomical-based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment.Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic ValueComparison of open with laparoscopic distal pancreatectomy: a single institution's transition over a 7-year period.Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancerClinical necessity of the immunohistochemical reassessment of para-aortic lymph nodes in resected pancreatic ductal adenocarcinoma.Multidisciplinary management of resectable adenocarcinoma of the pancreatic head.Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas.Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.
P2860
Q26748880-C2283F07-E4A4-4A91-AD57-CEA1B67B6301Q27022231-C8625971-4E75-4283-AE3F-26A34A6075A5Q28075892-19350642-F36F-4573-92A3-BFFAE2CEE2CDQ28076803-EBA7B745-1830-439E-88D9-806938871455Q28087060-E344115D-8F9F-414A-AAEE-2FBBD438E05CQ30238706-E78383BD-4417-4FF0-A86D-B5E76063D9AAQ31102361-941087E9-203E-447A-9243-40E8FB5A0A00Q33679644-565CA551-702A-4087-B196-E099837A2A6FQ33759924-66081E65-C097-4A15-8B9F-7EC1DB305453Q33791048-24138EA2-1D80-494B-AA85-1289EC2D730EQ33819380-9E862ADC-25FA-4451-9605-7B4F1D59074EQ33831911-42818CF9-DAE8-4A1B-8C39-FF0AF9455E4EQ33919105-19E82559-F3E1-4C98-9153-9FDF8D2824A1Q34067852-E9F1AE58-CB47-4223-AD53-B0FDA1BF5AD2Q34140498-B4735FA3-C4C5-42B3-A3C3-B69D4D93DDBDQ34184533-9CE23875-0893-451D-86D6-18AC2A13BE3BQ34408283-CE2A1AFD-B52D-4CED-8F33-C7774AD23C5FQ34409883-84E863ED-1F61-44ED-9700-EF18274BECCDQ34538845-BE31FA0E-73A6-4B5B-A753-46E65D4D7751Q34635042-049F6CE6-D0CF-4C23-A149-BE62802FFB31Q34732306-DAF2FB47-1D26-4F31-AF44-1B722CFECEC2Q34986932-99C2CA3D-3CAF-4A30-8C33-777879E350A9Q35147520-91F956AB-DF81-4409-ACAB-F06125553809Q35160584-A82763B5-DFC7-47F2-8CAA-593B230EC010Q35183700-0F5DE483-9EA4-4466-8F82-2F371CCED5D5Q35194671-4BE1F71C-9110-406D-B4EB-881711365A03Q35895395-4C10760D-00C2-4A4E-A19C-1581242E5892Q36020137-ADA7719F-4979-4732-B776-E8D79B68F598Q36130588-B8A24F4C-F950-4DB6-B7B0-B84BE186811FQ36322006-1A311E21-40F6-4E4F-820F-2F075D248830Q36401628-3CBFF733-D8D3-4A31-AE65-A3A157B88144Q36609378-40A568D1-5025-4C4D-B957-69D4547BAA0CQ36792362-FCEC36E1-E1C8-42E9-AE66-FCFAEBF62219Q37037126-34C794DB-69AB-4A77-B8DB-B4ACE498E47FQ37086658-8AF702E0-1C81-4A45-BB68-CF277A913741Q37269610-6F0BBE1C-D37A-4018-AA5D-08278B29EF1FQ37300020-545BBB25-BAD1-4F18-AB08-E79D3B4C2932Q37350307-C5F92C79-F2F9-4580-A725-B258B3C99DA7Q37389360-89E78C3D-838A-48E4-B061-7DBD5B87E49FQ37401414-C3A2DF91-CD8D-43F0-9B92-B4AB4EE17AB1
P2860
A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A margin-negative R0 resection ...... survival in pancreatic cancer.
@en
A margin-negative R0 resection ...... survival in pancreatic cancer.
@nl
type
label
A margin-negative R0 resection ...... survival in pancreatic cancer.
@en
A margin-negative R0 resection ...... survival in pancreatic cancer.
@nl
prefLabel
A margin-negative R0 resection ...... survival in pancreatic cancer.
@en
A margin-negative R0 resection ...... survival in pancreatic cancer.
@nl
P2093
P1476
A margin-negative R0 resection ...... survival in pancreatic cancer.
@en
P2093
C Max Schmidt
Eric A Wiebke
James A Madura
Joseph E Krug
Keith D Lillemoe
Lewis E Jacobson
Nick J Zyromski
Thomas J Howard
P2888
P304
1338-45; discussion 1345-6
P356
10.1016/J.GASSUR.2006.09.008
P577
2006-12-01T00:00:00Z
P6179
1019401808